We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
all report title image
  • Published In : Feb 2022
  • Code : CMI4919
  • Pages : 90
  • Formats :
      Excel and PDF
  • Industry : Medical Devices
Ingographics Image

For detecting the disturbance between specific sequences in DNA or RNA, molecular diagnostics tests are used, which may be associated with disease. The other factors which lead to various diseases are disturbance between single nucleotide polymorphism, rearrangements, insertions, and others. Infectious diseases, virology, oncology and STDs are the diseases that are diagnosed by utilizing molecular diagnostic test.

Molecular diagnostics has the capacity of detecting specific disease which access in supplying accurate medicine to patients. On research and development of precision medicine various government economies are focused on diagnostic tests, which is estimated to drive the growth of the U.S., Europe, and Asia Pacific molecular diagnostics market over the forecast period.

The U.S., Europe, and Asia Pacific molecular diagnostics market is estimated to be valued at US$ 7,147 Mn in 2021 and is expected to witness a robust CAGR of 10.7% during the forecast period (2021-2028).

Market Dynamics

Increasing applications of biomarkers, new product launches by market players with increasing government initiatives, increasing demand for molecular diagnostic tests, and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive growth of the U.S., Europe, and Asia Pacific molecular diagnostics market.

The growth of molecular diagnostics market is expected to increase the research and development for identification of biomarkers which leads to new molecular diagnostic tests development. For instance, in February 2018, authorization to Banyan Biomarkers, Inc., a biotech company, was given by the U.S. FDA (Food and Drug Administration) for traumatic brain injury, for first diagnostic blood test.

Key features of the study:

  • This report provides in-depth analysis of the U.S., Europe, and Asia Pacific molecular diagnostics market provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the U.S., Europe, and Asia Pacific molecular diagnostics market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Abbott Laboratories, Hologic, Inc., Grifols, S.A., Qiagen N.V., F.Hoffmann-La Roche Ltd., Siemens Healthineers, Becton, Dickinson and Company, Beckmann Coulter, Inc., Bio-Rad Laboratories, and Thermo Fisher Scientific Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The U.S., Europe, and Asia Pacific molecular diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S., Europe, and Asia Pacific molecular diagnostics market

Detailed Segmentation:

  • U.S., Europe, and Asia Pacific Molecular Diagnostics Market, by Product Type:
    • Reagents
    • Kits & Instruments
  • U.S., Europe, and Asia Pacific Molecular Diagnostics Market, by Technology:
    • PCR-based
      • Liquid Biopsy Testing
      • Tissue Testing
    • NGS-based
      • Liquid Biopsy Testing
      • Tissue Testing
  • U.S., Europe, and Asia Pacific Molecular Diagnostics Market, by Application:
    • Genetic Testing
    • Oncology
    • Microbiology
    • STDs
    • Blood Screening
    • Virology
    • Tissue Typing
    • Prenatal Diagnosis
    • Others
  • U.S., Europe, and Asia Pacific Molecular Diagnostics Market, by End Users:
    • Hospitals
    • Clinics
    • Ambulatory Surgery Centers
  • U.S., Europe, and Asia Pacific Molecular Diagnostics Market, by Country:
    • U.S.
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Company Profiles
    • Abbott Laboratories*
      • Company highlights
      • Product Portfolio
      • Key Highlights
      • Financial performance
      • Strategies
    • Hologic, Inc.
    • Grifols, S.A.
    • Qiagen N.V.
    • Hoffmann-La Roche Ltd.
    • Siemens Healthineers,
    • Becton, Dickinson and Company,
    • Beckmann Coulter, Inc.
    • Bio-Rad Laboratories
    • Thermo Fisher Scientific Inc.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Technology
      • Market Snippet, By Application
      • Market Snippet, By End Users
      • Market Snippet, By Country
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Product approval and launches
    • Merges and Acquisitions
    • Key development
    • Regulatory Scenario
    • Reimbursement Scenario
    • Brand Analysis
    • PEST Analysis
    • Pricing Analysis
    • Technology Advancement
  4. U.S., Europe, and Asia Pacific Molecular Diagnostics Market – Impact of Coronavirus (COVID-19) Pandemic
    • Overall Impact of COVID-19
    • COVID-19 Epidemiology
  5. U.S., Europe, and Asia Pacific Molecular Diagnostics Market, By Product Type, 2021 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Reagents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Kits & Instruments
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  6. U.S., Europe, and Asia Pacific Molecular Diagnostics Market, By Technology, 2021 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • PCR-based
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
        • Liquid Biopsy Testing
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
        • Tissue Testing
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • NGS-based
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
        • Liquid Biopsy Testing
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
        • Tissue Testing
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  7. U.S., Europe, and Asia Pacific Molecular Diagnostics Market, By Application, 2021 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Oncology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Genetic Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Microbiology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • STDs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Blood Screening
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Virology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Tissue Typing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Prenatal Diagnosis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  8. U.S., Europe, and Asia Pacific Molecular Diagnostics Market, By End Users, 2021 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Ambulatory Surgery Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  9. U.S., Europe, and Asia Pacific Molecular Diagnostics Market, By Country, 2021 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, For Regions, 2018–2028
    • U.S.
      • Market Size and Forecast, By Product Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, By Technology, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, By Application, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, By End Users, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
    • Europe
      • Market Size and Forecast, By Product Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, By Technology, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, By Application, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, By End Users, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, By Technology, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, By Application, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, By End Users, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
  10. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis   
      • Abbott Laboratories
        • Company highlights
        • Product Portfolio
        • Key Highlights
        • Financial performance
        • Strategies
      • Hologic, Inc.
        • Company highlights
        • Product Portfolio
        • Key Highlights
        • Financial performance
        • Strategies
      • Grifols, S.A.,
        • Company highlights
        • Product Portfolio
        • Key Highlights
        • Financial performance
        • Strategies
      • Qiagen N.V.,
        • Company highlights
        • Product Portfolio
        • Key Highlights
        • Financial performance
        • Strategies
      • F.Hoffmann-La Roche Ltd.,
        • Company highlights
        • Product Portfolio
        • Key Highlights
        • Financial performance
        • Strategies
      • Siemens Healthineers
        • Company highlights
        • Product Portfolio
        • Key Highlights
        • Financial performance
        • Strategies
      • Becton, Dickinson and Company
        • Company highlights
        • Product Portfolio
        • Key Highlights
        • Financial performance
        • Strategies
      • Beckmann Coulter, Inc.
        • Company highlights
        • Product Portfolio
        • Key Highlights
        • Financial performance
        • Strategies
      • Bio-Rad Laboratories
        •  Company highlights
        • Product Portfolio
        • Key Highlights
        • Financial performance
        • Strategies
      • Thermo Fisher Scientific Inc.
        • Company highlights
        • Product Portfolio
        • Key Highlights
        • Financial performance
        • Strategies
  11. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 20 market data tables and 35 figures on "U.S., Europe, and Asia Pacific Molecular Diagnostics Market” – Country wide forecast to 2028

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount
Logo

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo